News Headlines Article

Ebola vaccine to be tested in humans at NIH Clinical Center in Maryland this fall
Washington Post

Government researchers, in collaboration with British drugmaker GlaxoSmithKline, will begin human trials next week for an experimental Ebola vaccine in the hopes of rushing the drug as quickly as possible to health workers and others at risk in West Africa.

The early-stage human trial is set to begin next week at the National Institutes of Health Clinical Center in Bethesda and will test both the safety of the vaccine and its ability to generate an immune response in patients. The initial trial will include about 20 adults, and officials said they hope to have initial safety data by the end of the year — a scientific and ethical necessity before distributing any new drug widely.